Wolff Wiese Magana’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.03K Hold
143
– – ﹤0.01% 740
2026
Q2
$3.08K Buy
143
+64
+81% +$1.19K ﹤0.01% 742
2026
Q1
$1.34K Hold
79
– – ﹤0.01% 834
2025
Q4
$1.48K Hold
79
– – ﹤0.01% 792
2025
Q3
$1.01K Hold
79
– – ﹤0.01% 847
2025
Q2
$1.33K Hold
79
– – ﹤0.01% 797
2025
Q1
$1.01K Hold
79
– – ﹤0.01% 856
2024
Q4
$1.39K Hold
79
– – ﹤0.01% 763
2024
Q3
$1.81K Hold
79
– – ﹤0.01% 754
2024
Q2
$1.81K Hold
79
– – ﹤0.01% 558
2024
Q1
$3.13K Buy
79
+23
+41% +$910 ﹤0.01% 458
2023
Q4
$2.22K Hold
56
– – ﹤0.01% 468
2023
Q3
$2.48K Hold
56
– – ﹤0.01% 524
2023
Q2
$2.44K Buy
+56
New +$2.46K ﹤0.01% 529
2022
Q4
– Sell
-483
Closed -$19K – 906
2022
Q3
$19K Hold
483
– – 0.02% 379
2022
Q2
$18K Sell
483
-14
-3% -$506 0.01% 421
2022
Q1
$20K Hold
497
– – 0.01% 424
2021
Q4
$21K Sell
497
-61
-11% -$2.65K 0.01% 424
2021
Q3
$24K Hold
558
– – 0.02% 394
2021
Q2
$26K Hold
558
– – 0.02% 364
2021
Q1
$26K Hold
558
– – 0.02% 361
2020
Q4
$24K Buy
+558
New +$28.6K 0.02% 354

Other funds holding NRC

Wolff Wiese Magana's NRC Position: Q3 2026 in Review

Wolff Wiese Magana held its NRC Health Common Stock (NRC) position steady in Q3 2026 at 143 shares worth $3.03K. The position accounts for ﹤0.01% of the portfolio, ranked #740.

Wolff Wiese Magana first reported a position in NRC in Q4 2020 and has held it in 22 quarters since. The position peaked at $26K in Q2 2021. 11 funds tracked by Wall St. Rank hold NRC as of Q3 2026.

  • Wolff Wiese Magana held 143 shares of NRC Health Common Stock worth $3.03K as of Q3 2026.
  • Wolff Wiese Magana left its NRC Health Common Stock share count unchanged in Q3 2026.
  • NRC Health Common Stock made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q3 2026, its #740 holding.
  • Wolff Wiese Magana first reported a position in NRC Health Common Stock in Q4 2020 and has held it in 22 quarters since.
  • Wolff Wiese Magana's NRC Health Common Stock position peaked at $26K in Q2 2021.
  • 11 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2026.

Based on Wolff Wiese Magana's 13F filing for Q3 2026, filed 15 Oct 2026.